RTW INVESTMENTS, LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$362,422,448
+3.1%
17,687,7720.0%7.65%
+14.3%
Q2 2023$351,456,030
+16.0%
17,687,7720.0%6.69%
+6.1%
Q1 2023$302,991,534
-12.5%
17,687,7720.0%6.31%
-10.7%
Q4 2022$346,149,698
+37.2%
17,687,772
+11.9%
7.07%
+21.5%
Q3 2022$252,213,000
+16.0%
15,802,8020.0%5.82%
+3.5%
Q2 2022$217,447,000
-13.2%
15,802,8020.0%5.62%
+8.3%
Q1 2022$250,632,000
-27.3%
15,802,8020.0%5.19%
+3.0%
Q4 2021$344,975,000
-26.5%
15,802,8020.0%5.04%
-28.9%
Q3 2021$469,601,000
-29.3%
15,802,802
+5.4%
7.08%
-29.3%
Q2 2021$663,920,000
-4.8%
14,990,286
-4.6%
10.02%
-8.0%
Q1 2021$697,287,000
-25.5%
15,715,286
-7.9%
10.88%
-30.7%
Q4 2020$935,582,000
+143.4%
17,060,211
+1.5%
15.70%
+69.6%
Q3 2020$384,334,000
+9.2%
16,812,4910.0%9.25%
-6.5%
Q2 2020$351,885,000
+50.0%
16,812,4910.0%9.90%
-1.9%
Q1 2020$234,534,000
-38.7%
16,812,4910.0%10.10%
-30.1%
Q4 2019$382,652,000
+98.8%
16,812,491
+1.4%
14.44%
+26.1%
Q3 2019$192,503,000
-22.6%
16,587,4910.0%11.45%
-13.9%
Q2 2019$248,812,000
-11.2%
16,587,491
+3.4%
13.29%
-30.5%
Q1 2019$280,250,000
+18.8%
16,037,4860.0%19.13%
-12.9%
Q4 2018$235,848,000
-36.0%
16,037,486
+7.1%
21.95%
-0.5%
Q3 2018$368,555,000
+27.3%
14,969,7440.0%22.07%
+5.7%
Q2 2018$289,448,000
+12.1%
14,969,7440.0%20.88%
-15.1%
Q1 2018$258,228,00014,969,74424.58%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders